TP53 and neoplasm: Kortekaas KE et al. further stratified p16-negative VSSC patients by using p53 IHC, and found that patients with p16-/p53mut tumor had the worst outcomes, with advanced stages, deeper invasion, and more frequent lymphovascular space invasion [7].